Indian Nexavar purchasing agent 13621079267 How much does a box of Sorafenib Nexavar cost?

( / () [Usage and Dosage] Recommended dosage: The recommended dosage of Nexavar (sorafenib) is each time (.), twice a day, on an empty stomach or with a low-fat or medium-fat diet.
( / () Instructions: Take orally, swallow with a glass of warm water. The treatment time should be continued until the patient cannot benefit clinically or an intolerable toxic reaction occurs. Dosage adjustment and special instructions for handling suspected adverse reactions. Including suspending or reducing the dosage of Nexavar (Sorafenib), if necessary, reducing the dosage of Nexavar (Sorafenib) to once a day or once every other day, each time. (.).
( / ( ) Adjust the dose accordingly according to skin toxicity
Grade skin adverse reactions include paralysis, hypoesthesia, paresthesia, numbness, painless swelling, erythema of hands and feet or discomfort but does not affect daily activities, etc. at any time , it is recommended that the dose be adjusted to continue using this product, and at the same time, local treatment is given to eliminate symptoms.
( / () grade skin adverse reactions are accompanied by painful erythema and swelling of the hands and feet, and/or discomfort in the hands and feet that affects daily life. For the first time When symptoms occur, adjust the dose to continue using this product, and give local treatment to eliminate symptoms. If symptoms do not improve within days or appear for the second or third time, interrupt treatment with this product until the toxicity is relieved to grade. When restarting During treatment with this product, reduce to a single dose (daily or every other day). When the fourth occurrence occurs, treatment with this product should be terminated.
( / () grade skin adverse reactions: desquamation, ulceration, Blistering, pain in the hands and feet, or severe hand and foot discomfort that causes the patient to be unable to work and live a normal life. When it occurs for the first or second time, treatment with this product should be interrupted until the toxicity is relieved to the lowest level. When treatment with this product is restarted, reduce to a single dose (daily or every other day). When the third occurrence occurs, treatment with this product should be discontinued.
( / () Pediatric patients There are no reports of Nexavar (sorafenib) being used in pediatric patients. Safety and effectiveness data. Gender and weight in the elderly (over 10 years old) No dose adjustment is required based on the patient's age (over 10 years old), gender or weight.
( / () Patients with hepatic impairment Patients with mild to moderate hepatic impairment No dose adjustment is required in patients ( and ). Nexavar (sorafenib) has not been studied in patients with severe hepatic impairment.
( / () Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment .There are no studies on the use of sorafenib in patients with severe renal impairment or on dialysis.